Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system-Reference-Cited by-同舟云学术

Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system

Published:2017-01-01 Issue:1 Volume:6 Page:1-8
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Wei Feixue¹,Sheng Wei¹,Wu Xin²,Yin Kai²,Lan Jian²,Huang Yue¹,Ma Xinjing¹,Zheng Ya¹,Zhuang Sijie¹,Huang Shoujie¹,Su Yingying¹,Li Mingqiang²,Wu Ting¹,Zhang Jun¹,Xia Ningshao¹

Affiliation:

1. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and PharmaceuticsSchool of Public Health, Xiamen University, Xiamen 361102, Fujian, China

2. Liuzhou Center for Disease Control and Prevention, Liuzhou 545027, Guangxi, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1038/emi.2017.100

Reference33 articles.

1. External Genital Warts: Diagnosis, Treatment, and Prevention

2. The psychosocial burden of human papillomavirus related disease and screening interventions

3. Impact of Human Papillomavirus-Related Lesions on Quality of Life: A Multicenter Hospital-Based Study of Women in Mainland China

4. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A simulation study;Human Vaccines & Immunotherapeutics;2023-08

2. Estimating the prevalence of non-cervical human papillomavirus infection in mainland China (PROGRESS-Plus): protocol of a national cross-sectional study;BMJ Open;2023-02

3. Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial;Human Vaccines & Immunotherapeutics;2022-07-14

4. Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China;Emerging Infectious Diseases;2020-10

5. Identification and evaluation of UL36 protein from Dermacentor silvarum salivary gland and its interaction with Anaplasma ovis VirB10;Parasites & Vectors;2020-02-27